Taking the Pulse of Neonatal Screening for Critical Congenital Heart Disease


This 3-part series, directed to nurse practitioners and physician assistants, is designed to take the learner from a comprehensive understanding of critical congenital heart disease, the imperatives of appropriate neonatal oximetry screening and implementation of standardized protocols nationwide, to discussion of the continuum of care from assessment and diagnosis to management decisions and follow-up post-discharge.


Learning Objectives

Upon completion of these activities, participants should be better able to:

  • Express more knowledge of, and competence with recognizing the seven specific lesions as primary targets for the life-threatening CCHD in an effort to avert misdiagnosis
  • Employ recent HHS, AAP, AHA guidance initiatives and clinical trials data when considering the timing of pulse-oximetry screening for CCHD in newborns
  • Evaluate the clinical trials data and public policy initiatives that support the use of pulse oximetry for CCHD in newborns

This educational activity is jointly sponsored by Medical Education Resources (MER), Nurse Practitioner Associates for Continuing Education (NPACE) and Haymarket Medical Education (HME), and supported by an educational grant from Covidien.

Each of the 3 articles offers 0.50  AMA PRA Category 1 CME Credit(s)™ and 0.50 contact hours of continuing nursing education.



Courses No Longer Offering Credit

HM 


These activities are supported by an educational grant from

and jointly sponsored by

  

PROGRAM FACULTY

PROGRAM CHAIR
Gerard R. Martin, MD
Co-Director, Children's National Heart Institute
Children's National Medical Center
Professor of Pediatrics
George Washington University
Washington, DC

Alex R. Kemper, MD, MPH, MS
Department of Pediatrics,
Community and Family Medicine
Duke University School of Medicine
Durham, NC

Elizabeth A. Bradshaw, MSN, RN, CPN
Coordinator for the Congenital Heart Disease Screening Program
Children's National Medical Center
Washington, DC